Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

7.58
Delayed Data
As of 3:59pm ET
 +0.46 / +6.46%
Today’s Change
2.56
Today|||52-Week Range
10.73
+35.84%
Year-to-Date
'Yuge' Sector Rotation Will Continue
Dec 01 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close7.12
Today’s open7.24
Day’s range7.24 - 7.65
Volume625,622
Average volume (3 months)724,570
Market cap$263.8M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+70.68%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp+0.03+5.89%
PPHMPPeregrine Pharmaceut...-0.49-2.43%
CARACara Therapeutics In...+0.23+2.42%
TRVNTrevena Inc+0.10+1.89%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts


Search for Jobs